144 related articles for article (PubMed ID: 30607440)
1. Nuclear localization of LDL receptor-related protein 1B in mammary gland carcinogenesis.
Asano Y; Takeuchi T; Okubo H; Saigo C; Kito Y; Iwata Y; Futamura M; Yoshida K
J Mol Med (Berl); 2019 Feb; 97(2):257-268. PubMed ID: 30607440
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of LDL receptor-related protein 1B in patients with gastric cancer.
Yasufuku I; Saigo C; Kito Y; Yoshida K; Takeuchi T
J Mol Histol; 2021 Apr; 52(2):165-172. PubMed ID: 33389427
[TBL] [Abstract][Full Text] [Related]
3. Expression and localization of estrogen receptor in human breast cancer and its clinical significance.
Li L; Wang Q; Lv X; Sha L; Qin H; Wang L; Li L
Cell Biochem Biophys; 2015 Jan; 71(1):63-8. PubMed ID: 25113640
[TBL] [Abstract][Full Text] [Related]
4. The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma.
Coulson R; Liew SH; Connelly AA; Yee NS; Deb S; Kumar B; Vargas AC; O'Toole SA; Parslow AC; Poh A; Putoczki T; Morrow RJ; Alorro M; Lazarus KA; Yeap EFW; Walton KL; Harrison CA; Hannan NJ; George AJ; Clyne CD; Ernst M; Allen AM; Chand AL
Oncotarget; 2017 Mar; 8(12):18640-18656. PubMed ID: 28416734
[TBL] [Abstract][Full Text] [Related]
5. Expression of beclin-1 in the microenvironment of invasive ductal carcinoma of the breast: correlation with prognosis and the cancer-stromal interaction.
Morikawa A; Takeuchi T; Kito Y; Saigo C; Sakuratani T; Futamura M; Yoshida K
PLoS One; 2015; 10(5):e0125762. PubMed ID: 25955408
[TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma.
Heinonen M; Bono P; Narko K; Chang SH; Lundin J; Joensuu H; Furneaux H; Hla T; Haglund C; Ristimäki A
Cancer Res; 2005 Mar; 65(6):2157-61. PubMed ID: 15781626
[TBL] [Abstract][Full Text] [Related]
7. NEAT1 negatively regulates miR-218 expression and promotes breast cancer progression.
Zhao D; Zhang Y; Wang N; Yu N
Cancer Biomark; 2017 Sep; 20(3):247-254. PubMed ID: 28946559
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of cytoplasmic SOX9 in invasive ductal carcinoma and metastatic breast cancer.
Chakravarty G; Moroz K; Makridakis NM; Lloyd SA; Galvez SE; Canavello PR; Lacey MR; Agrawal K; Mondal D
Exp Biol Med (Maywood); 2011 Feb; 236(2):145-55. PubMed ID: 21321311
[TBL] [Abstract][Full Text] [Related]
9. Early growth responsive gene 3 in human breast carcinoma: a regulator of estrogen-meditated invasion and a potent prognostic factor.
Suzuki T; Inoue A; Miki Y; Moriya T; Akahira J; Ishida T; Hirakawa H; Yamaguchi Y; Hayashi S; Sasano H
Endocr Relat Cancer; 2007 Jun; 14(2):279-92. PubMed ID: 17639044
[TBL] [Abstract][Full Text] [Related]
10. FBXO22 Possesses Both Protumorigenic and Antimetastatic Roles in Breast Cancer Progression.
Sun R; Xie HY; Qian JX; Huang YN; Yang F; Zhang FL; Shao ZM; Li DQ
Cancer Res; 2018 Sep; 78(18):5274-5286. PubMed ID: 29945959
[TBL] [Abstract][Full Text] [Related]
11. Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence.
Caruso JA; Karakas C; Zhang J; Yi M; Albarracin C; Sahin A; Bondy M; Liu J; Hunt KK; Keyomarsi K
Breast Cancer Res; 2014; 16(6):3417. PubMed ID: 25551582
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of β-catenin in invasive ductal breast carcinomas.
Abd El-Rehim D; Ali MM
J Egypt Natl Canc Inst; 2009 Jun; 21(2):185-95. PubMed ID: 21057570
[TBL] [Abstract][Full Text] [Related]
13. gamma-Secretase-mediated release of the low density lipoprotein receptor-related protein 1B intracellular domain suppresses anchorage-independent growth of neuroglioma cells.
Liu CX; Ranganathan S; Robinson S; Strickland DK
J Biol Chem; 2007 Mar; 282(10):7504-11. PubMed ID: 17227771
[TBL] [Abstract][Full Text] [Related]
14. Activated Akt signaling pathway in invasive ductal carcinoma of the breast: correlation with HER2 overexpression.
Park SS; Kim SW
Oncol Rep; 2007 Jul; 18(1):139-43. PubMed ID: 17549359
[TBL] [Abstract][Full Text] [Related]
15. Mean nuclear area and metallothionein expression in ductal breast tumors: correlation with estrogen receptor status.
El Sharkawy SL; Farrag AR
Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):108-12. PubMed ID: 18227734
[TBL] [Abstract][Full Text] [Related]
16. Targeting claudin-4 enhances chemosensitivity in breast cancer.
Luo Y; Kishi S; Sasaki T; Ohmori H; Fujiwara-Tani R; Mori S; Goto K; Nishiguchi Y; Mori T; Kawahara I; Kondoh M; Kuniyasu H
Cancer Sci; 2020 May; 111(5):1840-1850. PubMed ID: 32086991
[TBL] [Abstract][Full Text] [Related]
17. The transcriptional regulator TBX3 promotes progression from non-invasive to invasive breast cancer.
Krstic M; Macmillan CD; Leong HS; Clifford AG; Souter LH; Dales DW; Postenka CO; Chambers AF; Tuck AB
BMC Cancer; 2016 Aug; 16(1):671. PubMed ID: 27553211
[TBL] [Abstract][Full Text] [Related]
18. Correlation between nuclear grade and biological prognostic variables in invasive breast cancer.
Yang Q; Mori I; Sakurai T; Yoshimura G; Suzuma T; Nakamura Y; Nakamura M; Taniguchi E; Tamaki T; Umemura T; Kakudo K
Breast Cancer; 2001; 8(2):105-10. PubMed ID: 11342982
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 directly induces MCF-7 breast tumor cells to develop into exponentially growing, highly angiogenic and regionally invasive human ductal carcinoma xenografts.
Robertson FM; Mallery SR; Bergdall-Costell VK; Cheng M; Pei P; Prosperi JR; Ferrari M
Anticancer Res; 2007; 27(2):719-27. PubMed ID: 17465194
[TBL] [Abstract][Full Text] [Related]
20. Expression of metallothionein in invasive ductal breast cancer in relation to prognosis.
Zhang R; Zhang H; Wei H; Luo X
J Environ Pathol Toxicol Oncol; 2000; 19(1-2):95-7. PubMed ID: 10905514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]